This tumor-suppressive phenotype is mediated by the nANGPTL4 signal peptide through a novel intracellular mechanism that inhibits LAL activity, potentially leading to modulation of lipid and/or glucose metabolism [62]. This evidence concerns the gene LIPA and neoplasm.